(American Friends of Tel Aviv University) Prof. Shamgar Ben-Eliyahu of Tel Aviv University is combining two medications originally used to treat excessive stress and inflammatory responses, the culmination of 15 years of research on the connection between the body's stress responses, immune functions, and tumor metastasis.
If these trials are as successful as those recently concluded on animal models, long-term post-operative survival rates for cancer patients may increase by up to 300 percent.